Medfinder
Back to blog

Updated: January 23, 2026

Orgovyx Side Effects: What to Expect and When to Call Your Doctor

Author

Peter Daggett

Peter Daggett

Checking pharmacy inventory for Orgovyx medication

Learn what side effects Orgovyx (relugolix) commonly causes, which are serious and require immediate care, and practical tips for managing hot flashes, fatigue, and bone health.

Orgovyx (relugolix) is an effective androgen deprivation therapy (ADT) for advanced prostate cancer, but like all medications that lower testosterone, it comes with a range of side effects. Some are common and manageable; others are rare but serious and require immediate medical attention. This guide covers what to realistically expect and how to respond.

Why Does Orgovyx Cause Side Effects?

Orgovyx works by rapidly lowering testosterone to castrate levels (below 50 ng/dL). Most side effects stem from this profound testosterone suppression rather than from the drug itself. Testosterone plays a role in muscle mass, bone density, metabolism, sexual function, energy, and cardiovascular health — so its suppression affects many body systems. Understanding this helps explain why the side effects feel so broad.

Common Side Effects of Orgovyx (≥10% of Patients)

In the Phase 3 HERO trial, the most frequently reported side effects included:

Hot flashes (flushes): The most common side effect. Sudden episodes of warmth, sweating, and flushing, often occurring at night as well as during the day. These typically peak in the first few months.

Fatigue: A general sense of tiredness or lack of energy. Exercise and staying active can help reduce fatigue severity.

Musculoskeletal pain: Joint pain, back pain, and muscle aches are common during ADT. Staying active and maintaining muscle mass through resistance training is recommended.

Constipation and diarrhea: Both can occur; gastrointestinal changes are common in the first weeks of treatment.

Increased blood glucose: ADT can affect insulin sensitivity. Patients with diabetes or pre-diabetes should monitor blood sugar more closely.

Elevated triglycerides: Lipid panel changes are common on ADT. Your doctor will monitor your labs periodically.

Decreased hemoglobin (anemia): Testosterone helps stimulate red blood cell production; its suppression can cause mild anemia and contribute to fatigue.

Elevated liver enzymes (ALT/AST): Mild elevations are observed in some patients; typically asymptomatic but monitored with routine labs.

Beyond the clinical trial data, patients on long-term ADT with Orgovyx may also experience:

Bone density loss: Testosterone protects bone. ADT accelerates bone loss; ask your doctor about bone density monitoring and protective medications (bisphosphonates or denosumab).

Loss of libido and sexual function: Very common on ADT; testosterone suppression directly reduces sexual drive and can cause erectile dysfunction.

Gynecomastia (breast tissue growth): Some men experience breast tenderness or enlargement due to hormone imbalances.

Mood changes: Depression, irritability, or emotional changes are reported by some patients on ADT.

Weight gain and body composition changes: Decreased muscle mass and increased body fat are common. Supervised exercise can mitigate these changes.

Serious Side Effects — Call Your Doctor Immediately If You Experience:

Heart rhythm changes (QT prolongation): Orgovyx can prolong the QT interval, increasing the risk of dangerous heart arrhythmias. Symptoms include palpitations, dizziness, fainting, or an irregular heartbeat. Seek emergency care immediately if these occur.

Severe allergic reaction (angioedema): Rare but serious. Symptoms include swelling of the face, lips, tongue, or throat, difficulty breathing, or hives. Stop Orgovyx and seek emergency care immediately. This is a contraindication to further use.

Cardiovascular events: Although Orgovyx showed a lower cardiovascular event rate than leuprolide in clinical trials, all ADT carries cardiovascular risk. Report any chest pain, shortness of breath, or symptoms of stroke immediately.

Tips for Managing Orgovyx Side Effects

Hot flashes: Dress in layers, avoid triggers (spicy food, caffeine, alcohol), use fans. Ask your doctor about low-dose antidepressants (venlafaxine) or gabapentin, which can reduce hot flash frequency.

Fatigue and muscle loss: Regular aerobic exercise and resistance training (at least 150 minutes/week) are supported by clinical evidence to improve energy, preserve muscle mass, and improve quality of life on ADT.

Bone health: Take calcium and vitamin D as directed. Discuss bone-protective medications with your doctor if you'll be on ADT for more than 6 months.

Mood changes: Talk to your doctor about mental health support. Counseling, support groups, and in some cases antidepressants can help manage ADT-related mood changes.

Want to understand which other medications to avoid while on Orgovyx? Read our guide on Orgovyx drug interactions for a complete list.

Frequently Asked Questions

The most common side effects of Orgovyx (reported in ≥10% of patients) include hot flashes, fatigue, musculoskeletal pain, constipation, diarrhea, elevated blood glucose, elevated triglycerides, decreased hemoglobin, and elevated liver enzymes (ALT/AST). These are largely related to testosterone suppression, not the drug itself.

Orgovyx can prolong the QT/QTc interval, which in rare cases can cause dangerous heart rhythm problems. It should be used with caution in patients with heart disease, long QT syndrome, electrolyte abnormalities, or those taking other QT-prolonging drugs. Patients should report palpitations, dizziness, or fainting immediately. Importantly, Orgovyx showed a significantly lower rate of major cardiovascular events (2.9%) compared to leuprolide (6.2%) in the HERO trial.

Many ADT side effects improve after stopping Orgovyx. One key advantage of Orgovyx is that testosterone recovery after discontinuation is faster than with many injectable GnRH agonists — 55% of patients in a substudy returned to normal testosterone levels within 90 days of stopping. Hot flashes, sexual dysfunction, and fatigue typically improve as testosterone rises. Bone loss and some cardiovascular effects may persist, depending on the duration of therapy.

Orgovyx and leuprolide (Lupron) have broadly similar ADT side effect profiles since both suppress testosterone. However, there are differences: Orgovyx does not cause an initial testosterone flare (which leuprolide can), and Orgovyx showed lower rates of major cardiovascular events in the HERO trial. Orgovyx was associated with somewhat more diarrhea, while leuprolide was associated with more arthralgia and urinary tract infections.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Orgovyx also looked for:

32,848 have already found their meds with Medfinder.

Start your search today.

32K+
5-star ratingTrusted by 32,848 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?